Welcome to our dedicated page for CAMTEK SEC filings (Ticker: CAMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CAMTEK's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CAMTEK's regulatory disclosures and financial reporting.
Wasatch Advisors LP reports beneficial ownership of 3,529,165 ordinary shares of Camtek Ltd, representing 7.7% of the class. The filing shows Wasatch has sole dispositive power over 3,506,727 shares and reports no shared voting or dispositive power. The document contains two different figures for sole voting power in separate sections (2,458,296 and 2,485,296), which are presented as reported and are not reconciled within the filing.
The filing is submitted as a Schedule 13G/A by an investment adviser (Type IA) and includes a certification that the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Camtek Ltd (CAMT) submitted a Form 144 notice reporting a proposed sale of 21,321 ordinary shares through Oppenheimer & Co. Inc., with an aggregate market value of $1,844,906.13. The sale is scheduled approximately for 08/13/2025 and the shares are listed on Nasdaq. The form states the issuer has 45,449,306 shares outstanding, providing context for the transaction size.
The securities to be sold were acquired as restricted stock units from the issuer on 04/28/2021 (2,774 shares), 01/24/2022 (4,637 shares), and 01/16/2023 (13,910 shares), which together equal the 21,321 shares offered. The filing reports no securities sold in the past three months and includes the seller's standard representation that they are unaware of any undisclosed material adverse information; a trading-plan reference is noted but no plan adoption date is provided.
Camtek Ltd (CAMT) Form 144 filing discloses that an unidentified insider intends to sell 7,300 ordinary shares through broker Oppenheimer & Co. The planned transaction, scheduled on or about 08-07-2025, carries an aggregate market value of $594,147, based on the prevailing market price when the notice was prepared.
The shares represent roughly 0.016 % of Camtek’s 45.45 million shares outstanding, implying a modest dilution impact. The stock to be sold derives from previously granted restricted stock units (RSUs) acquired on 09-24-2020 (6,500 shares) and 08-18-2021 (800 shares). No shares were sold by the filer in the past three months, and the signer affirms possession of no undisclosed material adverse information.
While the filing is routine and compliant with Rule 144, it signals a limited insider disposition that investors may interpret as a marginally negative sentiment check rather than a material event for the company’s fundamentals.